Good publication practice for pharmaceutical companies
暂无分享,去创建一个
[1] Kenneth F. Schulz,et al. The CONSORT Statement , 1996 .
[2] P. Easterbrook,et al. Publication bias in clinical research , 1991, The Lancet.
[3] C. R. Reed,et al. Recent trends and controversies in industry-sponsored clinical trials. , 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[4] Rennie. Improving the conduct and reporting of clinical trials , 2000, JAMA.
[5] Aids to navigation , 2000, The Lancet.
[6] C M Kunin. Clinical investigators and the pharmaceutical industry. , 1978, Annals of internal medicine.
[7] Lois Ann Colaianni,et al. UNIFORM REQUIREMENTS FOR MANUSCRIPTS SUBMITTED TO BIOMEDICAL JOURNALS , 2000 .
[8] E Wager. Redefining authorship , 1996, BMJ.
[9] F. Davidoff. News from the International Committee of Medical Journal Editors , 2000, Annals of Internal Medicine.
[10] K. Dickersin. The existence of publication bias and risk factors for its occurrence. , 1990, JAMA.
[11] T. Bodenheimer,et al. Uneasy alliance--clinical investigators and the pharmaceutical industry. , 2000, The New England journal of medicine.
[12] I. Olkin,et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.
[13] Melissa S. Anderson,et al. Withholding research results in academic life science. Evidence from a national survey of faculty. , 1997, JAMA.
[14] R. Simes,et al. Publication bias: evidence of delayed publication in a cohort study of clinical research projects , 1997, BMJ.
[15] D. Rennie,et al. The contributions of authors. , 2000, JAMA.
[16] Gerd Antes,et al. Under-reporting of clinical trials is unethical , 2003, The Lancet.
[17] B. Gandevia,et al. DECLARATION OF HELSINKI. , 1964, The Medical journal of Australia.